Tianjin Chase Sun Pharmaceutical Co.,Ltd (300026.SZ)
CNY 3.58
(1.13%)
CNY 3.58
(1.13%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 11.83 Billion CNY | -6.3% |
| 2022 | 12.63 Billion CNY | 8.82% |
| 2021 | 11.6 Billion CNY | 14.02% |
| 2020 | 10.17 Billion CNY | 20.8% |
| 2019 | 8.42 Billion CNY | 12.6% |
| 2018 | 7.48 Billion CNY | 0.75% |
| 2017 | 7.42 Billion CNY | 2.02% |
| 2016 | 7.28 Billion CNY | 12.49% |
| 2015 | 6.47 Billion CNY | 112.68% |
| 2014 | 3.04 Billion CNY | 37.15% |
| 2013 | 2.21 Billion CNY | 23.15% |
| 2012 | 1.8 Billion CNY | 28.02% |
| 2011 | 1.4 Billion CNY | 9.97% |
| 2010 | 1.27 Billion CNY | 20.54% |
| 2009 | 1.06 Billion CNY | 388.98% |
| 2008 | 217.14 Million CNY | 24.06% |
| 2007 | 175.02 Million CNY | 65.72% |
| 2006 | 105.61 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 11.37 Billion CNY | -5.43% |
| 2024 Q1 | 12 Billion CNY | 1.45% |
| 2024 Q2 | 12.02 Billion CNY | 0.15% |
| 2023 FY | 11.83 Billion CNY | -6.3% |
| 2023 Q1 | 12.61 Billion CNY | -0.16% |
| 2023 Q4 | 11.83 Billion CNY | -4.39% |
| 2023 Q2 | 12.44 Billion CNY | -1.3% |
| 2023 Q3 | 12.37 Billion CNY | -0.55% |
| 2022 Q2 | 11.79 Billion CNY | 0.35% |
| 2022 Q3 | 11.99 Billion CNY | 1.67% |
| 2022 FY | 12.63 Billion CNY | 8.82% |
| 2022 Q1 | 11.75 Billion CNY | 1.28% |
| 2022 Q4 | 12.63 Billion CNY | 5.3% |
| 2021 Q4 | 11.6 Billion CNY | 1.12% |
| 2021 FY | 11.6 Billion CNY | 14.02% |
| 2021 Q1 | 10.54 Billion CNY | 3.63% |
| 2021 Q2 | 10.52 Billion CNY | -0.21% |
| 2021 Q3 | 11.47 Billion CNY | 9.04% |
| 2020 Q2 | 9.7 Billion CNY | 6.23% |
| 2020 FY | 10.17 Billion CNY | 20.8% |
| 2020 Q1 | 9.13 Billion CNY | 8.39% |
| 2020 Q3 | 10.07 Billion CNY | 3.85% |
| 2020 Q4 | 10.17 Billion CNY | 1.03% |
| 2019 Q2 | 8.1 Billion CNY | 5.79% |
| 2019 FY | 8.42 Billion CNY | 12.6% |
| 2019 Q4 | 8.42 Billion CNY | 1.43% |
| 2019 Q1 | 7.66 Billion CNY | 2.42% |
| 2019 Q3 | 8.3 Billion CNY | 2.46% |
| 2018 Q2 | 7.77 Billion CNY | 2.85% |
| 2018 Q3 | 7.73 Billion CNY | -0.53% |
| 2018 FY | 7.48 Billion CNY | 0.75% |
| 2018 Q1 | 7.56 Billion CNY | 1.82% |
| 2018 Q4 | 7.48 Billion CNY | -3.28% |
| 2017 Q1 | 7.34 Billion CNY | 0.81% |
| 2017 Q4 | 7.42 Billion CNY | 0.56% |
| 2017 FY | 7.42 Billion CNY | 2.02% |
| 2017 Q3 | 7.38 Billion CNY | 1.16% |
| 2017 Q2 | 7.3 Billion CNY | -0.52% |
| 2016 Q3 | 7.26 Billion CNY | 8.69% |
| 2016 FY | 7.28 Billion CNY | 12.49% |
| 2016 Q4 | 7.28 Billion CNY | 0.25% |
| 2016 Q2 | 6.68 Billion CNY | -1.22% |
| 2016 Q1 | 6.76 Billion CNY | 4.51% |
| 2015 Q3 | 4.34 Billion CNY | 4.96% |
| 2015 Q4 | 6.47 Billion CNY | 48.93% |
| 2015 FY | 6.47 Billion CNY | 112.68% |
| 2015 Q1 | 4.12 Billion CNY | 35.69% |
| 2015 Q2 | 4.14 Billion CNY | 0.27% |
| 2014 Q2 | 2.65 Billion CNY | 8.18% |
| 2014 FY | 3.04 Billion CNY | 37.15% |
| 2014 Q4 | 3.04 Billion CNY | 5.29% |
| 2014 Q3 | 2.89 Billion CNY | 8.86% |
| 2014 Q1 | 2.45 Billion CNY | 10.62% |
| 2013 Q4 | 2.21 Billion CNY | 8.28% |
| 2013 FY | 2.21 Billion CNY | 23.15% |
| 2013 Q1 | 1.86 Billion CNY | 3.37% |
| 2013 Q2 | 1.97 Billion CNY | 5.77% |
| 2013 Q3 | 2.04 Billion CNY | 4.02% |
| 2012 Q3 | 1.62 Billion CNY | 3.23% |
| 2012 FY | 1.8 Billion CNY | 28.02% |
| 2012 Q2 | 1.57 Billion CNY | 8.56% |
| 2012 Q1 | 1.45 Billion CNY | 3.3% |
| 2012 Q4 | 1.8 Billion CNY | 10.59% |
| 2011 Q1 | 1.32 Billion CNY | 3.57% |
| 2011 Q4 | 1.4 Billion CNY | 7.86% |
| 2011 Q2 | 1.32 Billion CNY | 0.06% |
| 2011 FY | 1.4 Billion CNY | 9.97% |
| 2011 Q3 | 1.3 Billion CNY | -1.62% |
| 2010 Q1 | 1.04 Billion CNY | -1.22% |
| 2010 FY | 1.27 Billion CNY | 20.54% |
| 2010 Q4 | 1.27 Billion CNY | 7.99% |
| 2010 Q3 | 1.18 Billion CNY | 2.64% |
| 2010 Q2 | 1.15 Billion CNY | 10.09% |
| 2009 FY | 1.06 Billion CNY | 388.98% |
| 2009 Q2 | 246.99 Million CNY | 0.0% |
| 2009 Q4 | 1.06 Billion CNY | 285.91% |
| 2009 Q3 | 275.13 Million CNY | 11.39% |
| 2008 FY | 217.14 Million CNY | 24.06% |
| 2008 Q4 | 217.14 Million CNY | 0.0% |
| 2007 FY | 175.02 Million CNY | 65.72% |
| 2006 FY | 105.61 Million CNY | 0.0% |